ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

GADAVIST
Imaging agents
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

GADAVIST Rx

Generic Name and Formulations:
Gadobutrol 604.72mg/mL (1mmol/mL); soln for IV inj; preservative-free.

Company:
Bayer Healthcare Pharmaceuticals Inc.

Therapeutic Use:

Indications for GADAVIST:

For use in MRI of the CNS in adults and children (including term neonates) to detect and visualize areas with disrupted blood brain barrier and/or abnormal vascularity. MRI of the breast to assess the presence and extent of malignant breast disease. For use in magnetic resonance angiography (MRA) in adults and children (including term neonates) to evaluate known or suspected supra-aortic or renal artery disease.

Adults and Children:

Premature infants: not established. Give by IV inj manually or by power injector (see full labeling). 0.1mL/kg (0.1mmol/kg), followed by a normal saline flush to ensure complete injection. MRI of CNS: at a rate of ~2mL/sec. MRA (adults): at a rate of ~1.5mL/sec, followed by 30mL saline flush at the same rate.

Boxed Warning:

Nephrogenic systemic fibrosis.

Warnings/Precautions:

Increased risk of nephrogenic systemic fibrosis in chronic kidney disease or acute kidney injury; avoid use. Screen for renal dysfunction. Do not exceed recommended dose and allow sufficient time for drug elimination before re-administration. Have emergency resuscitative equipment available. History of asthma or other allergic disorders. Monitor for signs/symptoms of hypersensitivity reactions during and after administration. Increased risk of gadolinium retention with multiple lifetime doses, in pregnant patients, children, and those with inflammatory conditions; minimize repetitive imaging studies. Gadavist MRI may overestimate extent of malignancy in the diseased breast up to 50% of patients. Low sensitivity for significant arterial stenosis. Avoid extravasation. Elderly. Pregnancy. Nursing mothers: consider interrupting nursing and pumping/discarding breast milk for up to 18hrs after inj.

Pharmacological Class:

Gadolinium-based contrast agent.

Adverse Reactions:

Headache, nausea, dizziness; hypersensitivity reactions.

How Supplied:

Single-dose vials (2mL)—15; (7.5mL, 10mL, 15mL)—20; Single-use prefilled syringes (7.5mL, 10mL, 15mL)—5


Data provided by MPR.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs